Accelerated radiotherapy for T1, 2 glottic carcinoma: Analysis of results with KI-67 index

International Journal of Radiation Oncology Biology Physics

Volumn 47, Issue 1, 2000, Pages 81-88

  Sakata, Koh ichi ^a   Oouchi, Atushi ^a   Nagakura, Hisayasu ^a   Akiba, Hidenari ^a   Tamakawa, Mistuharu ^a   Koito, Kazumitsu ^a   Hareyama, Masato ^a   Asakura, Kohji ^a   Satoh, Masaaki ^a   Ohtani, Seiji ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Accelerated fractionation; Growth fraction; Ki 67 index; Radiation therapy; T1 glottic cancer; T2 glottic cancer

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL TRIAL; EDEMA; FEMALE; GLOTTIS; HUMAN; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SALVAGE THERAPY; STATISTICAL ANALYSIS; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT OUTCOME; VOICE;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; CARCINOMA, SQUAMOUS CELL; DOSE FRACTIONATION; FEMALE; GLOTTIS; HUMANS; KI-67 ANTIGEN; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; NEOPLASM STAGING; SALVAGE THERAPY; STOMATITIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034176129     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00409-0     Document Type: Article

References (29)

1. Mendenhall WM, Parsons JT, Mancuso AA; et al. Larynx. In: Perez CA, Brady LW, editors. Principles and practice of radiation oncology. Philadelphia-New York: Lippincott-Raven; 1997. p.1069-1094.
2. Sakata K., Aoki Y., Karasawa K., et al. Radiation therapy in early glottic carcinoma Uni- and multivariate analysis of prognostic factors affecting local control . Int J Radiat Oncol Biol Phys. 30:1994;1059-1064.
3. Nishimura Y., Nagata Y., Okajima K., et al. Radiation therapy for T1,2 glottic carcinoma Impact of overall treatment time on local control . Radiother Oncol. 40:1996;225-232.
4. Mendenhall W.M., Parsons J.T., Million R.R., et al. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy Relationship of dose-fractionation factors to local control and complications . Int J Radiat Oncol Biol Phys. 15:1988;1267-1273.
5. Small W. Jr, Mittal B.B., Brand W.N., et al. Results of radiation therapy in early glottic carcinoma Multivariate analysis of prognostic and radiation therapy variables . Radiology. 183:1992;789-794.
6. Barendsen G.W. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys. 8:1982;1981-1997.
7. Fowler J.F., Lindstrom M.J. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys. 23:1992;457-467.
8. Lindstrom M.J., Fowler J.F. Re-analysis of the time factor in local control by radiotherapy of T3T4 squamous cell carcinoma of the larynx. Int J Radiat Oncol Biol Phys. 21:1991;813-817.
9. Parsons J.T., Bova F.J., Million R.R. A re-evaluation of split-course technique for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 6:1980;1645-1652.
10. Horiot J.C., Bontemps P., van den Bogaert W., et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers Results of the EORTC 22851 randomized trial [see comments] . Radiother Oncol. 44:1997;111-121.
11. Dische S., Saunders M., Barrett A., et al. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer [see comments]. Radiother Oncol. 44:1997;123-136.
12. Wang C.C., Blitzer P.H., Suit H.D. Twice-a-day radiation therapy for cancer of the head and neck. Cancer. 55:1985;2100-2104.
13. Gerdes J., Schwab U., Lemke H., et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer. 31:1983;13-20.
14. Key G., Becker M.H., Baron B., et al. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Investig. 68:1993;629-636.
15. Hall EJ. Time, dose, and fractionation in radiotherapy. In: Radiobiology for the radiologist. Philadelphia: Lippincott-Raven; 1994. p.211-229.
16. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 31:1995;1341-1346.
17. McCormick D., Chong H., Hobbs C., et al. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1. Histopathology. 22:1993;355-360.
18. Trott K.R., Kummermehr J. What is known about tumour proliferation rates to choose between accelerated fractionation or hyperfractionation? Radiother Oncol. 3:1985;1-9.
19. Fowler J.F. Fractionated radiation therapy after Strandqvist. Acta Radiol Oncol. 23:1984;209-216.
20. Bentzen S.M., Thames H.D. Clinical evidence for tumor clonogen regeneration Interpretations of the data [see comments] . Radiother Oncol. 22:1991;161-166.
21. Fowler J.F. How worthwhile are short schedules in radiotherapy? A series of exploratory calculations [see comments]. Radiother Oncol. 18:1990;165-181.
22. Bourhis J., Dendale R., Hill C., et al. Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks. Int J Radiat Oncol Biol Phys. 35:1996;471-476.
23. Corvo R., Giaretti W., Sanguineti G., et al. In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen. J Clin Oncol. 13:1995;1843-1850.
24. Wilson G.D., Dische S., Saunders M.I. Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy. Radiother Oncol. 36:1995;189-197.
25. Hoyer M., Jorgensen K., Bundgaard T., et al. Lack of predictive value of potential doubling time and iododeoxyuridine labelling index in radiotherapy of squamous cell carcinoma of the head and neck. Radiother Oncol. 46:1998;147-155.
26. Tubiana M., Courdi A. Cell proliferation kinetics in human solid tumors Relation to probability of metastatic dissemination and long-term survival . Radiother Oncol. 15:1989;1-18.
27. Nakano T., Oka K. Differential values of Ki-67 index and mitotic index of proliferating cell population An assessment of cell cycle and prognosis in radiation therapy for cervical cancer . Cancer. 72:1993;2401-2408.
28. Raybaud-Diogene H., Fortin A., Morency R., et al. Markers of radioresistance in squamous cell carcinomas of the head and neck A clinicopathologic and immunohistochemical study . J Clin Oncol. 15:1997;1030-1038.
29. Roland N.J., Rowley H., Scraggs M., et al. MIB-1 and involucrin expression in laryngeal squamous carcinoma The relationship to host and tumour factors and survival . Clin Otolaryngol. 21:1996;429-438.